Dominga Racanelli
Dominga Racanelli
1Unit of Oncogenetics and Functional Oncogenomics, Centro di Riferimento Oncologico di Aviano (CRO Aviano) IRCCS, National Cancer Institute, Aviano, Italy
1,†,
Monica Brenca
Monica Brenca
1Unit of Oncogenetics and Functional Oncogenomics, Centro di Riferimento Oncologico di Aviano (CRO Aviano) IRCCS, National Cancer Institute, Aviano, Italy
1,†,
Davide Baldazzi
Davide Baldazzi
1Unit of Oncogenetics and Functional Oncogenomics, Centro di Riferimento Oncologico di Aviano (CRO Aviano) IRCCS, National Cancer Institute, Aviano, Italy
1,†,
Frauke Goeman
Frauke Goeman
2Department of Research, Diagnosis and Innovative Technology, IRCCS Regina Elena National Cancer Institute, Rome, Italy
2,†,
Beatrice Casini
Beatrice Casini
2Department of Research, Diagnosis and Innovative Technology, IRCCS Regina Elena National Cancer Institute, Rome, Italy
2,†,
Biagio De Angelis
Biagio De Angelis
3Department of Onco-Haematology and Cell and Gene Therapy Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
3,
Marika Guercio
Marika Guercio
3Department of Onco-Haematology and Cell and Gene Therapy Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
3,
Giuseppe Maria Milano
Giuseppe Maria Milano
3Department of Onco-Haematology and Cell and Gene Therapy Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
3,
Elena Tamborini
Elena Tamborini
4Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
4,
Adele Busico
Adele Busico
4Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
4,
Gianpaolo Dagrada
Gianpaolo Dagrada
4Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
4,
Cecilia Garofalo
Cecilia Garofalo
5Advanced Translational Research Laboratory, Veneto Institute of Oncology IOV – IRCCS, Padua, Italy
5,
Chiara Caruso
Chiara Caruso
5Advanced Translational Research Laboratory, Veneto Institute of Oncology IOV – IRCCS, Padua, Italy
5,
Antonella Brunello
Antonella Brunello
6Medical Oncology 1, Department of Oncology, Veneto Institute of Oncology IOV – IRCCS, Padua, Italy
6,
Ymera Pignochino
Ymera Pignochino
7Division of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy
7,
Enrico Berrino
Enrico Berrino
8Unit of Pathology, Candiolo Cancer Institute FPO-IRCCS, Candiolo, Italy
8,
Giovanni Grignani
Giovanni Grignani
7Division of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy
7,
Katia Scotlandi
Katia Scotlandi
9Laboratory of Experimental Oncology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy
9,
Alessandro Parra
Alessandro Parra
9Laboratory of Experimental Oncology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy
9,
Claudia Maria Hattinger
Claudia Maria Hattinger
9Laboratory of Experimental Oncology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy
9,
Toni Ibrahim
Toni Ibrahim
10Osteoncology and Rare Tumors Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy
10,
Laura Mercatali
Laura Mercatali
10Osteoncology and Rare Tumors Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy
10,
Alessandro De Vita
Alessandro De Vita
10Osteoncology and Rare Tumors Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy
10,
Maria Vincenza Carriero
Maria Vincenza Carriero
11Tumor Progression Unit, Department of Experimental Oncology, Istituto Nazionale Tumori Fondazione “G. Pascale” IRCCS, Naples, Italy
11,
Matteo Pallocca
Matteo Pallocca
2Department of Research, Diagnosis and Innovative Technology, IRCCS Regina Elena National Cancer Institute, Rome, Italy
2,
Rossella Loria
Rossella Loria
2Department of Research, Diagnosis and Innovative Technology, IRCCS Regina Elena National Cancer Institute, Rome, Italy
2,
Renato Covello
Renato Covello
2Department of Research, Diagnosis and Innovative Technology, IRCCS Regina Elena National Cancer Institute, Rome, Italy
2,
Marta Sbaraglia
Marta Sbaraglia
12Department of Pathology, Azienda Ospedaliera Universitaria di Padova, Padua, Italy
12,
Angelo Paolo Dei Tos
Angelo Paolo Dei Tos
12Department of Pathology, Azienda Ospedaliera Universitaria di Padova, Padua, Italy
13Department of Medicine, University of Padua School of Medicine, Padua, Italy
12,13,
Rita Falcioni
Rita Falcioni
2Department of Research, Diagnosis and Innovative Technology, IRCCS Regina Elena National Cancer Institute, Rome, Italy
2,*,‡,
Roberta Maestro
Roberta Maestro
1Unit of Oncogenetics and Functional Oncogenomics, Centro di Riferimento Oncologico di Aviano (CRO Aviano) IRCCS, National Cancer Institute, Aviano, Italy
1,*,‡
1Unit of Oncogenetics and Functional Oncogenomics, Centro di Riferimento Oncologico di Aviano (CRO Aviano) IRCCS, National Cancer Institute, Aviano, Italy
2Department of Research, Diagnosis and Innovative Technology, IRCCS Regina Elena National Cancer Institute, Rome, Italy
3Department of Onco-Haematology and Cell and Gene Therapy Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
4Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
5Advanced Translational Research Laboratory, Veneto Institute of Oncology IOV – IRCCS, Padua, Italy
6Medical Oncology 1, Department of Oncology, Veneto Institute of Oncology IOV – IRCCS, Padua, Italy
7Division of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy
8Unit of Pathology, Candiolo Cancer Institute FPO-IRCCS, Candiolo, Italy
9Laboratory of Experimental Oncology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy
10Osteoncology and Rare Tumors Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy
11Tumor Progression Unit, Department of Experimental Oncology, Istituto Nazionale Tumori Fondazione “G. Pascale” IRCCS, Naples, Italy
12Department of Pathology, Azienda Ospedaliera Universitaria di Padova, Padua, Italy
13Department of Medicine, University of Padua School of Medicine, Padua, Italy
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
✉*Correspondence: Rita Falcioni rita.falcioni@ifo.gov.it
*Roberta Maestro maestro@cro.it
This article was submitted to Cancer Molecular Targets and Therapeutics, a section of the journal Frontiers in Oncology
†These authors have contributed equally to this work and share first authorship
‡These authors share last authorship
Received 2020 May 11; Accepted 2020 May 13; Collection date 2020.
Keywords: sarcoma, molecular diagnosis, fusion transcripts, NGS, anchored multiplex PCR, hybrid capture-based panel
Copyright © 2020 Racanelli, Brenca, Baldazzi, Goeman, Casini, De Angelis, Guercio, Milano, Tamborini, Busico, Dagrada, Garofalo, Caruso, Brunello, Pignochino, Berrino, Grignani, Scotlandi, Parra, Hattinger, Ibrahim, Mercatali, De Vita, Carriero, Pallocca, Loria, Covello, Sbaraglia, Dei Tos, Falcioni and Maestro.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.